COVID-SEROKLIR Trademark

Trademark Overview


On Friday, August 21, 2020, a trademark application was filed for COVID-SEROKLIR with the United States Patent and Trademark Office. The USPTO has given the COVID-SEROKLIR trademark a serial number of 90130727. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 4, 2022. This trademark is owned by Kantaro Biosciences LLC. The COVID-SEROKLIR trademark is filed in the Medical Instrument Products category with the following description:

Medical diagnostic apparatus for testing for viruses; Medical testing and analysis equipment and apparatus; Blood testing apparatus; Medical apparatus for collecting, processing and testing blood, bodily fluids, biological and cellular samples and specimens; Medical diagnostic instruments for the analysis of blood, body fluids, biological and cellular samples and specimens; Apparatus for analysis of biological materials for medical and clinical purposes; Medical apparatus and instruments for laboratory analysis, clinical diagnosis and treatment of infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Tools and devices for medical diagnostics; Medical apparatus, instruments and devices for diagnostic use, namely, apparatus for medical diagnostic testing and analysis in the fields of infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmo...
covid-seroklir

General Information


Serial Number90130727
Word MarkCOVID-SEROKLIR
Filing DateFriday, August 21, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 4, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 5, 2021

Trademark Statements


Goods and ServicesMedical diagnostic apparatus for testing for viruses; Medical testing and analysis equipment and apparatus; Blood testing apparatus; Medical apparatus for collecting, processing and testing blood, bodily fluids, biological and cellular samples and specimens; Medical diagnostic instruments for the analysis of blood, body fluids, biological and cellular samples and specimens; Apparatus for analysis of biological materials for medical and clinical purposes; Medical apparatus and instruments for laboratory analysis, clinical diagnosis and treatment of infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Tools and devices for medical diagnostics; Medical apparatus, instruments and devices for diagnostic use, namely, apparatus for medical diagnostic testing and analysis in the fields of infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Medical test kits consisting primarily of probes, assays, reagents, media, solutions, buffers, antibodies, antigens, control materials, membranes, plasma, diagnostic chemicals, calibrators, swabs for medical purposes, plates, vessels, tubes, pipettes, trays, panels, slides, cards and bottles for testing blood, biological fluids, bodily fluids, biological and cellular samples and specimens and tissue for the presence of antibodies for medical and clinical purposes; Medical diagnostic apparatus and devices for detecting, testing and analyzing SARS-CoV-2 and COVID-19; Diagnostic apparatus for detecting infection; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Containers for the collection and preservation and transport of blood, biofluids, bodily fluids, biological and cellular samples and specimens obtained from humans and animals for medical or veterinary purposes; all the foregoing related to the detection, diagnosis, testing, prevention and/or treatment of SARS-CoV-2, COVID-19 and antibodies, antigens, diseases, illnesses, viruses, disorders and/or infections related to SARS-CoV-2 or COVID-19

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, September 24, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKantaro Biosciences LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10036

Party NameKantaro Biosciences LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10036

Trademark Events


Event DateEvent Description
Tuesday, July 5, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 4, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 30, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 5, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 5, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 15, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 30, 2021ASSIGNED TO EXAMINER
Friday, August 27, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 26, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 26, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 6, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 6, 2021NON-FINAL ACTION E-MAILED
Saturday, March 6, 2021NON-FINAL ACTION WRITTEN
Monday, February 22, 2021ASSIGNED TO EXAMINER
Thursday, September 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 25, 2020NEW APPLICATION ENTERED IN TRAM